Lactobacillus sakei Probio65
Lactobacillus sakei Probio65, originally isolated from kimchi, has been studied for immune-modulating and anti-inflammatory properties across in vitro and animal models. A randomized, double-blind, placebo-controlled study examined oral administration of both live and heat-treated cells in children and adolescents in the context of atopic dermatitis. Animal research has examined gut microbiota composition and inflammatory markers in colitis models, while in vitro work has examined immunomodulatory activity. The evidence base is preliminary and early-stage. These are research topics, not findings; the papers do not establish that this strain treats or prevents any condition.
Where it's been studied Tags come from a conservative keyword scan of each paper's title, abstract, and summary. A tag is research coverage, not measured effect. How we classify this →
Share of this strain's 11 body-system-tagged papers that concern each system. Research coverage, not measured effect.
Symptoms in the research A tag means the paper's text names the symptom or condition — research coverage, not evidence of benefit. How we classify this →
Share of this strain's 7 symptom-tagged papers that mention each symptom or condition. Research coverage, not evidence of benefit.
Research Study-type filters use AI-classified labels, audited but not guaranteed — check the paper itself before leaning on one. How we classify this →
12 papers reference this strain in the probiotic database.
Discussion
Be the first to comment.
Sign in to join the discussion.